Publication
Newborn Screening for Homocystinuria Revealed a High Frequency of MAT I/III Deficiency in Iberian Peninsula
| dc.contributor.author | Marcão, Ana | |
| dc.contributor.author | Couce, María L. | |
| dc.contributor.author | Nogueira, Célia | |
| dc.contributor.author | Fonseca, Helena | |
| dc.contributor.author | Ferreira, Filipa | |
| dc.contributor.author | Fraga, José M. | |
| dc.contributor.author | Bóveda, M. Dolores | |
| dc.contributor.author | Vilarinho, Laura | |
| dc.date.accessioned | 2016-02-16T14:11:41Z | |
| dc.date.available | 2016-02-16T14:11:41Z | |
| dc.date.issued | 2015-02-01 | |
| dc.description | Acessível em: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375120/ | pt_PT |
| dc.description.abstract | Homocystinuria due to cystathionine β-synthase deficiency or "classical homocystinuria" is a rare autosomal recessive condition resulting in altered sulfur metabolism with elevated methionine and homocysteine in plasma and homocystine in urine. This condition is characterized by a high clinical heterogeneity, which contributes to late clinical diagnosis, usually only made after irreversible damage has occurred. Treatment is effective if started before clinical symptoms. The analysis of methionine levels by tandem mass spectrometry (MS/MS) allows the newborn screening for homocystinuria, but false-positive results can be frequently obtained and lead to the unwanted identification of methionine adenosyl transferase (MAT I/III) deficiency. This latter condition is biochemically characterized by isolated persistent hypermethioninemia, accompanied in some individuals with slightly elevated levels of homocysteine in plasma. A dominant form of MAT I/III deficiency, associated with mutation p.R264H, seems to be very frequent in the Iberian Peninsula and usually has a clinically benign course. Both these metabolic disorders are screened in Galicia and Portugal since the introduction of the MS/MS technology, in 2000 and 2004, respectively, resulting in the identification of three patients with classical homocystinuria and 44 patients with MAT I/III deficiency. All but one heterozygous parent of MAT I/III patients, identified with the p.R264H mutation, are healthy adults around the age of 30/40. The implementation of a second-tier test for homocysteine in dried blood spots would considerably reduce the number of MAT I/III-deficient patients identified and improve the specificity and positive predictive value for classical homocystinuria screening. | pt_PT |
| dc.identifier.citation | JIMD Rep. 2015;20:113-20. doi: 10.1007/8904_2014_400. Epub 2015 Feb 1. | pt_PT |
| dc.identifier.doi | 10.1007/8904_2014_400 | pt_PT |
| dc.identifier.issn | 2192-8304 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/3330 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | SSIEM and Springer-Verlag Berlin Heidelberg | pt_PT |
| dc.relation.publisherversion | http://link.springer.com/chapter/10.1007%2F8904_2014_400 | pt_PT |
| dc.subject | Rastreio Neonatal | pt_PT |
| dc.subject | Homocistinúria | pt_PT |
| dc.subject | Deficiência em MAT I/III | pt_PT |
| dc.subject | Doenças Genéticas | pt_PT |
| dc.title | Newborn Screening for Homocystinuria Revealed a High Frequency of MAT I/III Deficiency in Iberian Peninsula | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 120 | pt_PT |
| oaire.citation.startPage | 113 | pt_PT |
| oaire.citation.title | Journal of Inherited Metabolic Disease Reports | pt_PT |
| oaire.citation.volume | 20 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |